BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 29573771)

  • 1. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
    Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
    Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of endoscopic endonasal underwater surgery using a combination of coblation and a lens-cleaning system for hemostasis in hereditary hemorrhagic telangiectasia.
    Sakaida H; Kobayashi M; Takeuchi K
    Auris Nasus Larynx; 2024 Jun; 51(3):512-516. PubMed ID: 38522355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
    Arndt G; Wai R; Stiel H
    J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia.
    Shovlin CL; Patel D; Bielowka A; Ledermann JA; Modarresi A; ; Bernabeu-Herrero ME; Aldred MA; Alsafi A
    Br J Haematol; 2024 Jan; 204(1):361-365. PubMed ID: 37872650
    [No Abstract]   [Full Text] [Related]  

  • 5. Taking thalidomide out of rehab.
    Akhurst RJ
    Nat Med; 2010 Apr; 16(4):370-2. PubMed ID: 20376039
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe epistaxis after posterior nasal nerve ablation requiring surgical intervention: A multi-center case series.
    Khan NS; Yoshiyasu Y; Wang BS; Khoudari A; Clerico DM; King JM; Steele TO; Dhanda AK; Takashima M; Ahmed OG
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1269-1272. PubMed ID: 38372028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute exacerbation of recurrent epistaxis and anemia in hereditary hemorrhagic telangiectasia: A case report.
    Li T; Ma J; Zhang H; Huang Y
    Asian J Surg; 2024 May; ():. PubMed ID: 38734551
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of hereditary hemorrhagic telangiectasia treated with cryotherapy.
    Wen SY; Huang YY
    J Cosmet Dermatol; 2024 May; 23(5):1929-1930. PubMed ID: 38297409
    [No Abstract]   [Full Text] [Related]  

  • 9. Refractory Epistaxis: A Map is Enough!
    Deng H; Wang W; He L; Yang Q
    Ear Nose Throat J; 2023 Mar; ():1455613231162029. PubMed ID: 36872526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia.
    Al-Samkari H
    J Intern Med; 2023 Dec; 294(6):684-686. PubMed ID: 37608622
    [No Abstract]   [Full Text] [Related]  

  • 11. Integration of genotypic data into clinical trial design and reporting in hereditary hemorrhagic telangiectasia could help personalize treatment.
    Modarresi A; Shovlin CL
    Haematologica; 2024 Jun; ():. PubMed ID: 38934059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The earliest description of possible viral haemorrhagic fever identified in ancient Greece.
    Ashrafian H
    J Travel Med; 2024 Mar; 31(2):. PubMed ID: 38263266
    [No Abstract]   [Full Text] [Related]  

  • 13. Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia.
    James M; Sehgal VS
    Eur J Intern Med; 2024 Jun; ():. PubMed ID: 38879351
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent Epistaxis and Purple Vascular Stains in an Elderly Patient.
    Singh S; Bhandari A; Handa S; Mahajan R
    Indian Dermatol Online J; 2024; 15(1):123-125. PubMed ID: 38283013
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetate of Lead in Epistaxis.
    Agnew DH
    Med Exam (Phila); 1851 Dec; 7(84):765-766. PubMed ID: 38121065
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    Donato M; Pimentel J; Cabral R; Escada P
    Acta Med Port; 2018 Jan; 31(1):63-66. PubMed ID: 29573771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
    Joshi H; Woodworth BA; Carney AS
    J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.